Five-year extended hormone therapy no better in breast cancer

(HealthDay)—Extending hormone therapy by five years does not provide benefit over a two-year extension among postmenopausal women with hormone receptor-positive breast cancer who had received five years of adjuvant endocrine therapy, according to a study published in the July 29 issue of the New England Journal of Medicine. Michael Gnant,…

Terry White Chemists Anastrozole

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS ANASTROZOLE Contains the active ingredient anastrozole Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about anastrozole. It does not contain…

Treatment of Gynecomastia

In many cases, Gynecomastia does not require urgent treatment. In pubertal boys the condition resolves by itself. When the condition is caused due to drugs or other underlying disease, it may resolve when the offensive drug is withdrawn or when the underlying disease is treated. Although complications of Gynecomastia are…

Rekovelle follitropin delta (rhu)

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REKOVELLE® (FOLLITROPIN DELTA) SOLUTION FOR INJECTION Solution for injection in a pre-filled pen follitropin delta (rhu) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about REKOVELLE. It does not contain all…

Crestor

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CRESTOR® DOC ID-001749028 V3.0 Rosuvastatin calcium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about CRESTOR. It does not contain all the information that is known about…

Provera

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PROVERA® Medroxyprogesterone acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PROVERA.It does not contain all the available information.It does not take the place of talking to your doctor or…

Evista

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EVISTA® V11219 Raloxifene hydrochloride Consumer Medicine Information What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine. Itdoes not contain all the available information and does…

Ezalo Composite Pack

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EZALO COMPOSITE PACK ezetimibe and rosuvastatin calcium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about EZALO COMPOSITE PACK. It does not contain all the available information.It does not take the…